stage breast cancer

Cancer patients who receive neoadjuvant therapy followed by mast...

admin — Wed, 24 Sep 2008 00:00:00 -0500

(University of Texas M. D. Anderson Cancer Center) Early-stage breast cancer patients who exhibit limited lymph node involvement may not require post-surgery radiation therapy when they receive neoadjuvant chemotherapy before a mastectomy, according to researchers from the University of Texas M. D. Anderson Cancer Center.

M. D. Anderson study finds racial disparities in radiation thera...

admin — Wed, 03 Sep 2008 00:00:00 -0500

(University of Texas M. D. Anderson Cancer Center) Black women are less likely than white women to receive radiation therapy after a lumpectomy, the standard of care for early stage breast cancer, according to a new study by researchers at The University of Texas M. D. Anderson Cancer Center.

Metformin increases pathologic complete response rates in breast...

admin — Mon, 02 Jun 2008 00:00:00 -0500

(University of Texas M. D. Anderson Cancer Center) Metformin, the common first-line drug for type 2 diabetes, may be effective in increasing pathologic complete response rates in diabetic women with early stage breast cancer who took the drug during chemotherapy prior to having surgery, paving the way for further research of the drug as a potential cancer therapy, according to researchers at the University of Texas M. D. Anderson Cancer Center.

Women 80 and older benefit from mammography, but few are screene...

admin — Tue, 22 Apr 2008 00:00:00 -0500

In the first study to assess mammography in women 80 and older, researchers found that having regular mammograms significantly decreases the risk of being diagnosed with late-stage breast cancer, but only about one-fifth of women in this age group receive them regularly.

Mammography may be beneficial to all women, regardless of age

admin — Mon, 21 Apr 2008 00:00:00 -0500

According to researchers at The University of Texas M. D. Anderson Cancer Center, mammography, the gold-standard for breast cancer screening and early detection, has shown to significantly reduce the risk of being diagnosed with advanced stage breast cancer in women over the age of 80, an age group currently without clear guidelines recommending regular screenings.